These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 11032642)
1. Systemic effects of intranasal steroids: an endocrinologist's perspective. Allen DB J Allergy Clin Immunol; 2000 Oct; 106(4 Suppl):S179-90. PubMed ID: 11032642 [TBL] [Abstract][Full Text] [Related]
2. Safety update regarding intranasal corticosteroids for the treatment of allergic rhinitis. Blaiss MS Allergy Asthma Proc; 2011; 32(6):413-8. PubMed ID: 22221434 [TBL] [Abstract][Full Text] [Related]
3. Safety of intranasal corticosteroids in acute rhinosinusitis. Demoly P Am J Otolaryngol; 2008; 29(6):403-13. PubMed ID: 19144302 [TBL] [Abstract][Full Text] [Related]
4. A review of the preclinical and clinical data of newer intranasal steroids used in the treatment of allergic rhinitis. Lumry WR J Allergy Clin Immunol; 1999 Oct; 104(4 Pt 1):S150-8. PubMed ID: 10518812 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic Index (TIX) for intranasal corticosteroids in the treatment of allergic rhinitis. Schafer T; Schnoor M; Wagenmann M; Klimek L; Bachert C Rhinology; 2011 Aug; 49(3):272-280. PubMed ID: 21858255 [TBL] [Abstract][Full Text] [Related]
7. Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications. Derendorf H; Meltzer EO Allergy; 2008 Oct; 63(10):1292-300. PubMed ID: 18782107 [TBL] [Abstract][Full Text] [Related]
8. Effects of intranasal corticosteroids on adrenal, bone, and blood markers of systemic activity in allergic rhinitis. Wilson AM; Sims EJ; McFarlane LC; Lipworth BJ J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):598-604. PubMed ID: 9802367 [TBL] [Abstract][Full Text] [Related]
10. Once-daily mometasone furoate nasal spray: efficacy and safety of a new intranasal glucocorticoid for allergic rhinitis. Davies RJ; Nelson HS Clin Ther; 1997; 19(1):27-38; discussion 2-3. PubMed ID: 9083706 [TBL] [Abstract][Full Text] [Related]
11. A review of the pharmacology and pharmacokinetics of inhaled fluticasone propionate and mometasone furoate. Crim C; Pierre LN; Daley-Yates PT Clin Ther; 2001 Sep; 23(9):1339-54. PubMed ID: 11589253 [TBL] [Abstract][Full Text] [Related]
12. Once-daily budesonide aqueous nasal spray for allergic rhinitis: a review. Stanaland BE Clin Ther; 2004 Apr; 26(4):473-92. PubMed ID: 15189745 [TBL] [Abstract][Full Text] [Related]
13. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. 194-079 Study Group. Mandl M; Nolop K; Lutsky BN Ann Allergy Asthma Immunol; 1997 Oct; 79(4):370-8. PubMed ID: 9357385 [TBL] [Abstract][Full Text] [Related]
14. Reader's response to "comparison of once-daily intranasal corticosteroids for the treatment of allergic rhinitis: are they all the same?". Philpot EE MedGenMed; 2006 Apr; 8(2):3; author reply 2. PubMed ID: 16926742 [No Abstract] [Full Text] [Related]
15. Mometasone furoate nasal spray: a review of safety and systemic effects. Zitt M; Kosoglou T; Hubbell J Drug Saf; 2007; 30(4):317-26. PubMed ID: 17408308 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of intranasal steroid spray (mometasone furoate) on treatment of patients with seasonal allergic rhinitis: comparison with oral corticosteroids. Karaki M; Akiyama K; Mori N Auris Nasus Larynx; 2013 Jun; 40(3):277-81. PubMed ID: 23127728 [TBL] [Abstract][Full Text] [Related]
17. Cost efficiency of intranasal corticosteroid prescribing patterns in the management of allergic rhinitis. Reissman D; Price T; Leibman CW J Manag Care Pharm; 2004 Jan; 10(1 Suppl):S9-13. PubMed ID: 14720101 [TBL] [Abstract][Full Text] [Related]